Nervous system diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age greater than 18 years; confirmed medical diagnosis of Parkinson's disease with a degree of severity between 1 and 3 according to the HOEHN & YAHR classification or stroke diagnosed six months ago; ability to understand and perform respiratory maneuvers with appropriate technique; absence of pulmonary or neuromuscular disease; except Parkinson's disease.
Exclusion criteria
Exclusion criteria: Will not be included in the study, individuals who present cognitive alterations according to the Mini Mental State Examination, observing the following score; if illiterate; score less than 19 points; with 1 to 3 years of schooling; score below 23 points; with 4 to 7 years of schooling; score below 24 points, and above 7 years of schooling; score less than 28 points. They present osteomioarticular lesions that make physical activity impossible; chronic uncontrolled diseases such as hypertension; diabetes mellitus and chronic pain. Unstable cardiovascular diseases such as acute heart failure; recent myocardial infarction; unstable angina and uncontrolled arrhythmias. Lung or other diseases that adversely affect the respiratory pump, including asthma and chronic obstructive pulmonary disease. Use of alcohol and other toxic substances; have facial paralysis or difficulty in sealing the mouthpiece during training. In addition to the aforementioned criteria; participants will be excluded in cases of absences exceeding three at the end of eight weeks of treatment; present osteomioarticular or cardiovascular changes acquired during the treatment period that make physical activity and / or inspiratory muscle training impossible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| When assessing respiratory muscle strength through manovacuometry and functional capacity through the six-minute walk test, after respiratory muscle training protocol with line resistor associated with neurofuncinal rehabilitation protocol; It is expected to find improvement in the functional capacity of individuals with stroke and Parkinson's, after respiratory muscle training. | — |
Secondary
| Measure | Time frame |
|---|---|
| When evaluating the effect of respiratory muscle training through manovacuometry on inspiratory and expiratory muscle strength; It is expected to find an increase in respiratory muscle strength.;When evaluating the effect of respiratory muscle training through manovacuometry; It is expected to find increased cough effectiveness and lung volumes and capacities assessed by spirometry.;When evaluating the effect of respiratory muscle training through manovacuometry; It is expected to find an increase in respiratory endurance assessed by maximum voluntary ventilation in the spirometry device. | — |
Countries
Brazil
Contacts
Universidade Federal da Bahia